Abbott Coughs Up $23M To Settle Patent Fraud Claims
Abbott Laboratories and French partner Fournier Industrie et Sante have agreed to pay 23 states and the District of Columbia $22.5 million to settle claims that the drug companies blocked generics...To view the full article, register now.
Already a subscriber? Click here to view full article